Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors

Figure 3 Receiver operating characteristic analysis of the model prediction for acute variceal bleeding. A: Training cohort; B: Validation cohort. The area under the curve in training cohort and validation cohort were 0861 (95%CI: 0.802-0.920) and 0.816 (95%CI: 0.714-0.919) respectively. Optimal cutoff: 0.132 (sensitivity 70.5%, specificity 89.5%). AUC: Area under the curve.